Merck & Co Inc

Catalyst Watch: Meta earnings, Kroger event, and Black Monday turns 39

Seeking Alpha · 3 d ago

Moderna falls ahead of cancer vaccine data next week

Seeking Alpha · 3 d ago

Weight-loss drug developers line up to tap lucrative market as competition heats up

Reuters · 3 d ago

Moderna outweighs bearish views ahead of cancer vaccine data

Seeking Alpha · 4 d ago

Why Healthcare Stocks Are Hot When the AI Trade Runs Cold — Barrons.com

Dow Jones Newswires · 4 d ago

Lilly, Merck, AbbVie Stocks Surge. Why Healthcare Is Rallying Today. — Barrons.com

Dow Jones Newswires · 5 d ago

Here's What to Buy After Hot CPI Puts an October Fed Rate Hike Back on the Table — Barrons.com

Dow Jones Newswires · 5 d ago

Pharma sector doubles down on AI to slash costs, timelines

Reuters · 5 d ago

Key facts: Merck (MRK) SAC‑TMT improves survival; Oct 26 webcast

TradingView · 5 d ago

Zydus-Formycon Keytruda Biosimilar FYB206 Accepted For USFDA Review

Businessworld · 5 d ago

Paul J. Diaz elected to Merck board, joins Audit and Research Committees

TradingView · 6 d ago

BioNTech's mRNA cancer therapy misses first goal in head and neck trial

Reuters · 6 d ago

AbbVie, Eli Lilly among mega-cap healthcare stocks with A+ profitability grades

Seeking Alpha · 6 d ago

Merck & Co., Inc., Rahway, N.J., USA Adds Paul J. Diaz to Board

TradingView · 6 d ago

Paul J. Diaz Elected to Merck & Co., Inc., Rahway, N.J., USA Board of Directors

BusinessWire · 6 d ago

Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline And Continued Innovative Potential Of Existing Portfolio At ESMO 2026

Reuters · 6 d ago

Merck & Co., Inc., Rahway, N.J., USA to Unveil First-Time Phase 3 Oncology Results at ESMO 2026

TradingView · 6 d ago

Merck & Company, Inc. Stock 12‑Month Price Target Raised to $157.72, Implies 8% Upside

TradingView · 7 d ago

Merck Is Maintained at Neutral by Citigroup

Dow Jones Newswires · 7 d ago